Mitra Biotech Closes $27.4M Series B Round | GenomeWeb

NEW YORK (GenomeWeb) – Indian personalized medicine startup Mitra Biotech announced today that it has raised $27.4 million through a Series B financing round.

Participants in the financing included new investors Sequoia India and Sands Capital Ventures, which co-led the round, and RA Capital Management. Also participating were existing investors Accel and Tata Capital Innovations Fund. In conjunction with the Series B round, Sequoia and Sands will become members of Mitra's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.